Project Details
Description
C928-011: A Randomized, Double-blind, Placebo-controlled, Phase 2b study to Evaluate Safety and Efficacy of DUR-928 in Subjects with Alcoholic Hepatitis
| Status | Active |
|---|---|
| Effective start/end date | 12/9/20 → 12/31/25 |
Funding
- DURECT CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.